ArticleTherapeutic advances in hematology2024

The effectiveness and safety of octocog alfa in patients with hemophilia A: up to 7-year follow-up of the real-world AHEAD international study.

Margareth C Ozelo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.